...
首页> 外文期刊>Journal of toxicology and environmental health, Part B. Critical reviews >Development of a database on key characteristics of human carcinogens
【24h】

Development of a database on key characteristics of human carcinogens

机译:一种关于人致癌物关键特征数据库的发展

获取原文
获取原文并翻译 | 示例

摘要

A database on mechanistic characteristics of human carcinogenic agents was developed by collecting mechanistic information on agents identified as human carcinogens (Group 1) by the International Agency for Research on Cancer (IARC) in the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A two-phase process is described for the construction of the database according to 24 toxicological endpoints, derived from appropriate test systems that were acquired from data obtained from the mechanisms sections of the IARC Monographs (Section 4) and a supplementary PubMed search. These endpoints were then aligned with 10 key characteristics of human carcinogens that reflect the broader attributes of these agents relating to the development of cancer in humans. The considerations involved in linking of toxicological endpoints to key characteristics are described and specific examples of the determination of key characteristics for six specific agents (tamoxifen, hepatitis B virus, arsenic, ultraviolet and solar radiation, tobacco smoking, and dioxin) are provided. Data for humans and animals were tabulated separately, as were results for in-vivo and for in-vitro sources of information. The database was constructed to support a separate analysis of the expression of these endpoints by 86 Group 1 carcinogens, in-vivo and in-vitro along with an analysis of the key characteristics of these agents.
机译:通过在IARC专着研究人体癌症(IARC)中鉴定为人致癌物(第1组)的药物信息,对人体癌(IARC)的代理商进行了对人体致癌风险的评估来开发了人致癌药物的机制信息数据库。根据24个毒理终点的构建数据库的构建,从由从IARC专着(第4节)的机制部分和补充的副本搜索所获得的数据获取的适当测试系统,描述了两相处理。然后将这些终点与人致癌物质的10个关键特征对齐,其反映了与人类癌症发育有关的这些药剂的更广泛的属性。提供了将毒理学终点与关键特征联系起来的考虑,并提供了六种特定试剂的关键特性的具体实例(Tamoxifen,乙型肝炎病毒,砷,紫外线和太阳辐射,烟草吸烟和二恶英)。单独制止人类和动物的数据,因为体内的结果和用于体外信息来源。构建数据库以支持将这些终点表达的单独分析与86组1癌,体内和体外的表达分析,以及这些药剂的关键特征的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号